Skip to main content

European Medicines Research Training Network

Objective

EMTRAIN is an essential element for the success of the IMI Education & Training (E&T) Call Topics in Europe (current and future). It will establish a pan-European platform of excellence for education and training covering the whole life-cycle of medicines from basic research through clinical development to pharmaco-vigilance. It will underpin the successful delivery of the current and future IMI-funded E&T projects, and by 2013 will have defined the IMI E&T vision.
In collaboration with the different IMI E&T projects EMTRAIN will ensure training
programmes are tailored in a coordinated way for current and future professionals involved in biomedical R&D. Flexibility and mobility of scientists is required to take advantage of the variety of opportunities at the pan-European level, and to understand European needs in biomedical and pharmaceutical medicines sciences. This capacity building project will build up the infrastructure for the other E&T projects and in future calls initiated by IMI, and will facilitate mobility between academia, industry, regulators, and other relevant stakeholders/potential employers.
Based on extensive mapping of existing resources in Europe and on a gap and overlap
analysis, the consortium will develop and implement a strategy for pan-European expansion,for harmonisation and accreditation of continuing professional development (CPD) programmes in context of life-long learning under the umbrella of the IMI cross-project LifeTrain initiative (WP4/7). The consortium will provide a comprehensive registry of Master level and PhD programmes, as well as of CPD programmes. It will provide an overview of existing innovative learning concepts, tools and methodologies in conjunction with the other IMI E&T projects that will support the content for the IMI education programmes. National implementation will be facilitated through close contacts with national university authorities, ministries of higher education, and through the availability of national liaison contact persons.
After implementation in a core group of institutions, extension is planned both within the countries represented in EMTRAIN and in additional countries, helped by dissemination and communication activities. The harmonisation and the modular nature of these programmes will allow trans-disciplinary curricula as well as trans-border and trans-sectoral mobility, and PhD programmes will be designed to foster industry/academia mobility and collaboration.
The public Consortium is made up of the six pan-European biomedical science (BMS)
research infrastructures from the ESFRI roadmap, and the Medizinische Universitaet Wien
as managing entity. The six ESFRI-BMS research infrastructures cover a broad spectrum of
competences from molecules to humans: structural biology (Instruct), bioinformatics
(ELIXIR), animal models (INFRAFRONTIER), biobanks (BBMRI), translational research
(EATRIS) and clinical research (ECRIN). These distributed infrastructures are based on
resources and facilities located in a majority of EU countries, and have their own education and training programmes. EMTRAIN can therefore take advantage of their broad spectrum of competences, of their pan-European dimension, of their close contacts with national authorities (national ministries of higher education and research are partners in these initiatives), and of already existing national liaisons. Members of the six ESFRI-BMS infrastructures will be responsible for leading the work packages WPs 2-9 in collaboration with members of the EFPIA.
The EFPIA consortium has considerable experience in education and training; management;
provides a pan-European geographical outreach, and draws on an extensive external
network of contacts. Therefore, the EFPIA consortium will not only be able to provide specific input relating to the needs of the pharmaceutical industry but, by contributing to the work packages in partnership with the public consortium, will also

Call for proposal

IMI-JU-01-2008
See other projects for this call

Coordinator

ASTRAZENECA AB
Address
Vastra Maelarhamnen
151 85 Sodertaelje
Sweden
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Principal investigator
Michael Hardman (Dr.)
Administrative Contact
Eva Lindgren (-)

Participants (29)

MEDIZINISCHE UNIVERSITAET WIEN
Austria
EU contribution
€ 1 266 786
Address
Spitalgasse 23
1090 Wien
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Markus Mueller (Univ.-Prof. Dr.)
KAROLINSKA INSTITUTET
Sweden
EU contribution
€ 662 060
Address
Nobels Vag 5
17177 Stockholm
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Thomas Walstam (Mr.)
Karolinska University Hospital

Participation ended

Sweden
EU contribution
€ 60 110
Address
Karolinska Universitets Sjukhuset, Solna
171 76 Stockholm
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Administrative Contact
Pierre Lafolie (Dr)
THE UNIVERSITY OF MANCHESTER
United Kingdom
EU contribution
€ 750 470
Address
Oxford Road
M13 9PL Manchester
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Liz Fay (Ms)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
France
EU contribution
€ 157 200
Address
101 Rue De Tolbiac
75654 Paris
Activity type
Research Organisations
Administrative Contact
Annick Bertault (Mrs)
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Germany
EU contribution
€ 768 930
Address
Meyerhofstrasse 1
69117 Heidelberg
Activity type
Research Organisations
Administrative Contact
Phil Irving (Dr)
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
Germany
EU contribution
€ 215 400
Address
Inhoffenstrasse 7
38124 Braunschweig
Activity type
Research Organisations
Administrative Contact
Michael Strätz (Dr.)
MEDIZINISCHE UNIVERSITAT GRAZ
Austria
EU contribution
€ 15 445
Address
Auenbruggerplatz 2
8036 Graz
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Karin Bonvecchio (Mag.)
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE
France
EU contribution
€ 106 844
Address
Rue Laurent Fries 1
67404 Illkirch Graffenstaden
Activity type
Research Organisations
Administrative Contact
Steve BROOKS (Dr)
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Germany
EU contribution
€ 1 200
Address
Ingolstadter Landstrasse 1
85764 Neuherberg
Activity type
Research Organisations
Administrative Contact
Juergen Ertel (Dr.)
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom
EU contribution
€ 50 400
Address
University Offices, Wellington Square
OX1 2JD Oxford
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Jenny Hayward (Ms)
Genzyme Europe B.V.
Netherlands
Address
Gooimeer
1411 DD Naarden
Administrative Contact
Ingeborg Steneker (Mrs)
NOVARTIS PHARMA AG
Switzerland
Address
Lichtstrasse 35
4056 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Barbara Stolz (Dr)
Bayer Pharma AG
Germany
Address
Muellerstrasse 178
13353 Berlin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Burkhardt Neumann (Mr.)
PFIZER LIMITED

Participation ended

United Kingdom
Address
Ramsgate Road
CT13 9NJ Sandwich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Olga Krylova (Dr)
F. HOFFMANN-LA ROCHE AG
Switzerland
Address
Grenzacherstrasse 124
4070 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Niggi Iberg (Dr)
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.
United Kingdom
Address
Great West Road 980
TW89GS Brentford
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Sally Miles (-)
UCB BIOPHARMA
Belgium
Address
Allee De La Recherche 60
1070 Bruxelles
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Simon DRESSE (Mr.)
NOVO NORDISK A/S
Denmark
Address
Novo Alle 1
2880 Bagsvaerd
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Jorgen Dirach (Dr.)
SANOFI-AVENTIS DEUTSCHLAND GMBH
Germany
Address
Bruningstrasse 50
65929 Frankfurt Am Main
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Flavia Bach (-)
BOEHRINGER INGELHEIM INTERNATIONALGMBH
Germany
Address
Binger Strasse
55218 Ingelheim
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Rolf Göggel (Dr.)
JANSSEN PHARMACEUTICA NV
Belgium
Address
Turnhoutseweg 30
2340 Beerse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Koen Meeussen (Dr.)
ORION OYJ
Finland
Address
Orionintie 1
02200 Espoo
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Reijo Salonen (Dr)
ALMIRALL SA
Spain
Address
General Mitre 151
08022 Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Jose-Luis Diaz (Dr)
H. LUNDBECK AS
Denmark
Address
Ottiliavej 7-9
2500 Valby
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Lise Tøttrup Brennum (MSc)
ESTEVE PHARMACEUTICALS, SA
Spain
Address
Passeig De La Zona Franca 109, 4A Planta
08038 Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Eduard Valenti (Dr)
Ministry of Human Resources, Medical Research Council, National Healthcare Service Center
Hungary
EU contribution
€ 58 400
Address
Arany János
1051 Budapest
Administrative Contact
György Blaskó (Prof. Dr.)
PharmaTrain Federation
Switzerland
EU contribution
€ 202 000
Address
Klingelbergstr.
4056 Basel
Administrative Contact
Leonilde Vaz (Ms)
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC)
Austria
EU contribution
€ 9 754
Address
Neue Stiftingtalstrasse 2/B/6
8010 Graz
Activity type
Research Organisations
Administrative Contact
Markus Pasterk (Mag.)